Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Public ClinicalTrials.gov record NCT06596252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double-blind, Randomized, Non-inferiority Phase III Trial on the Efficacy and Tolerability of 2 mg Once Daily vs. 1 mg Twice Daily Budesonide Orodispersible Tablets in Adults With Eosinophilic Esophagitis
Study identification
- NCT ID
- NCT06596252
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Dr. Falk Pharma GmbH
- Industry
- Enrollment
- 308 participants
Conditions and interventions
Conditions
Interventions
- Budesonide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 20, 2021
- Primary completion
- Nov 30, 2026
- Completion
- Feb 28, 2027
- Last update posted
- Apr 26, 2026
2021 – 2027
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dr. Falk Investigational Site | Scottsdale | Arizona | 85259 | Not yet recruiting |
| Dr. Falk Investigational Site | Little Rock | Arkansas | 72205 | Recruiting |
| Dr. Falk Investigational Site | La Jolla | California | 92037 | Recruiting |
| Dr. Falk Investigational Site | Lomita | California | 90717 | Withdrawn |
| Dr. Falk Investigational Site | San Diego | California | 92193 | Not yet recruiting |
| Dr. Falk Investigational Site | Doral | Florida | 83706 | Recruiting |
| Dr. Falk Investigational Site | New Port Richey | Florida | 34653 | Recruiting |
| Dr. Falk Investigational Site | Boise | Idaho | 83706 | Recruiting |
| Dr. Falk Investigational Site | Houma | Louisiana | 70363 | Recruiting |
| Dr. Falk Investigational Site | Marrero | Louisiana | 70072 | Recruiting |
| Dr. Falk Investigational Site | Boston | Massachusetts | 02111 | Recruiting |
| Wyoming | Ann Arbor | Michigan | 48109 | Not yet recruiting |
| Dr. Falk Investigational Site | Wyoming | Michigan | 49519 | Recruiting |
| Dr. Falk Investigational Site | Rochester | Minnesota | 55905 | Recruiting |
| Dr. Falk Investigational Site | Freehold | New Jersey | 07728 | Recruiting |
| Dr. Falk Investigational Site | Jackson | New Jersey | 08527 | Recruiting |
| Dr. Falk Investigational Site | New York | New York | 10075 | Recruiting |
| Dr. Falk Investigational Site | Chapel Hill | North Carolina | 27599-7080 | Recruiting |
| Dr. Falk Investigational Site | Cleveland | Ohio | 44195 | Recruiting |
| Dr. Falk Investigational Site | Mentor | Ohio | 44060 | Not yet recruiting |
| Wyoming | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Dr. Falk Investigational Site | Harlingen | Texas | 78550 | Recruiting |
| Dr. Falk Investigational Site | Salt Lake City | Utah | 85259 | Recruiting |
| Dr. Falk Investigational Site | Charlottesville | Virginia | 22903 | Not yet recruiting |
| Dr. Falk Investigational Site | Lynchburg | Virginia | 24502 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06596252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06596252 live on ClinicalTrials.gov.